17-AEP-GA

Modify Date: 2024-01-09 18:02:59

17-AEP-GA Structure
17-AEP-GA structure
Common Name 17-AEP-GA
CAS Number 75747-23-8 Molecular Weight 642.78
Density N/A Boiling Point N/A
Molecular Formula C34H50N4O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 17-AEP-GA


17-AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion. ADCs Toxin[1].

 Names

Name 17-AEP-GA

 17-AEP-GA Biological Activity

Description 17-AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion. ADCs Toxin[1].
Related Catalog
Target

HSP90

Traditional Cytotoxic Agents

References

[1]. Katarzyna Miekus, et al. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion. Oncol Rep. 2012 Nov;28(5):1903-9.

 Chemical & Physical Properties

Molecular Formula C34H50N4O8
Molecular Weight 642.78
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

17-AEP-GA suppliers

17-AEP-GA price

Related Compounds: More...
17-DMAP-GA
169521-68-0
17-GMB-APA-GA
256337-10-7
[17-(5-ethyl-6-methyl-hept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dodecanoate
20242-97-1
17,17a-Dihydroxy-D-homoandrosta-4,17-dien-3-one
30298-69-2
17-propynylestra-1,3,5-triene-3,17-diol dicyclopentadienyl dimolybdenum tetracarbonyl
101859-58-9
17,21-dihydroxy-9-thiocyanato-pregn-4-ene-3,11,20-trione
100267-05-8
17,21-dihydroxy-3,11,20-trioxo-pregn-4-ene-6α-carbonitrile
100267-08-1
17-[1,3]dioxolan-2-yl-heptadeca-6,9-diyne
6009-34-3
17-oxoestra-1,3,5(10),15-tetraen-3-yl acetate
59169-10-7
4-methoxy-2,5-dimethyl-N-(4-{[6-(3-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)benzene-1-sulfonamide
1019098-83-9
N-(4-{[6-(3-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide
1019098-85-1
4-methoxy-2,3-dimethyl-N-(4-{[6-(3-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)benzene-1-sulfonamide
1019098-87-3
4-ethoxy-N-(4-{[6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)benzene-1-sulfonamide
1019098-89-5
3,4-dimethoxy-N-(4-{[6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)benzene-1-sulfonamide
1019098-91-9
4-ethyl-N-(4-{[6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)benzene-1-sulfonamide
1019098-93-1
2-methoxy-5-methyl-N-(4-((6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyridazin-3-yl)amino)phenyl)benzenesulfonamide
1019098-95-3
4-methoxy-2,5-dimethyl-N-(4-{[6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)benzene-1-sulfonamide
1019098-97-5
N-(4-{[6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide
1019099-00-3
4-methoxy-2,3-dimethyl-N-(4-{[6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyridazin-3-yl]amino}phenyl)benzene-1-sulfonamide
1019099-03-6